PDL Adds A New Biologic To Its Royalty-Bearing Lineup
More reasons why we like our potential base hit with PDL BioPharma shares and options
Vanda And The $1 Billion Question With Fanapt
Will Vanda's Fanapt sales be as huge as some analysts suggest?
Transcript of Dendreon at BIO Conference
Read what Dendreon's CEO had to say about Provenge's manufacturing process and the future.
Transcript of PDL BioPharma at BIO Conference
Read what PDL's CEO had to say about patent issues, dividend plans, and the future
PDL BioPharma Shares on sale for Christmas?
A possible options trade with this former biotech darling in time for the holidays
Vanda Fanapt FDA Approval Conference Call Transcript
Vanda Pharmaceuticals cc transcript discussing the FDA approval of its antipsychotic drug Fanapt
Dendreon IMPACT Results Conference Call Transcript
Transcript of Dendreon's April 28 conference call at the American Urological Assocation meeting
Daily Stock Price Δ
| DJIA | 10564.38 | |||||||
| NASDAQ | 2340.68 | |||||||
| S&P 500 | 1140.44 | |||||||
| AMGN | 57.76 | |||||||
| GENZ | 57.45 | |||||||
| GILD | 47.44 | |||||||
| BIIB | 57.84 | |||||||
| PFE | 17.23 | |||||||
| MRK | 37.04 | |||||||
| GSK | 37.72 | |||||||
| NVS | 54.64 | |||||||
| RHHBY.PK | 41.90 | |||||||
| BAY.DE | 47.71 | |||||||
| ^BTK | 1167.01 | |||||||
| ^NBI | 922.28 | |||||||
| ARQL | 3.51 | |||||||
| SNY | 38.18 | |||||||
| ITMN | 23.30 | |||||||